Predictors of multidisciplinary tumor board implementation in head and neck cancer: Global insights

Maniaci A 1 , Lechien JR 2 , Chiesa-Estomba C 3 , Maso V 4 , Kabagenyi F 3 , Gengler I 5 Show all authors , Fagan JJ 6 , Hao SP 7 , Kowalski LP 8 , Lyons B 9 , Razif MYM 10 , Marzouki HZ 11 , Parisi FM 12 , White M 6 , Michel J 4 , Fakhry N 3

Affiliations 

  • 1 Department of Medicine and Surgery, University of Enna ″Kore″, Enna, 94100, Italy. antonino.maniaci@unikore.it
  • 2 Division of Laryngology and Bronchoesophagology, EpiCURA Hospital, University of Mons, Mons, Belgium
  • 3 Head and Neck Study Group of the Young-Otolaryngologists of the International Federations of Oto-Rhino-Laryngological Societies (YO-IFOS), Marseille, France
  • 4 Department of Oto-Rhino-Laryngology Head and Neck Surgery, AP-HM, La Conception University Hospital, Aix Marseille Université, Marseille, 13006, France
  • 5 Facial Plastic and Reconstructive Surgery, Department of Otolaryngology - Head and Neck Surgery, University of Cincinnati College of Medicine, Cincinnati, OH, USA
  • 6 Division of Otolaryngology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa
  • 7 Department of Otolaryngology, Head and Neck Surgery, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan
  • 8 Head and Neck Surgery and Otorhinolaryngology Department, A C Camargo Cancer Center, Sao Paulo, Brazil
  • 9 St. Vincent's Health Melbourne, Melbourne, Australia
  • 10 Department of Otorhinolaryngology, Universiti Kebangsaan Malaysia Medical Centre, Kuala Lumpur, Malaysia
  • 11 Department of Otolaryngology- Head & Neck Surgery, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia
  • 12 Department of Medicine and Surgery, University of Enna ″Kore″, Enna, 94100, Italy
Eur Arch Otorhinolaryngol, 2026 Aug;283(8):5181-5189.
PMID: 42165882 DOI: 10.1007/s00405-026-10244-6

Abstract

OBJECTIVE: To identify institutional and organizational determinants associated with the adoption of multidisciplinary tumor boards (MDTBs) in head and neck cancer management across diverse healthcare settings.

METHODS: This cross-sectional analysis used data from 566 responses, corresponding to 457 unique centers across 101 countries participating in the IFOS-YO-IFOS global survey. Centers were categorized by income level, region, and case volume. Logistic regression identified predictors of systematic MDTB use.

RESULTS: Among responding centers, MDTBs were systematic in 89.1% of North America, 88.9% of European and 87.5% of Oceanian centers, compared with 37.5% in Africa and 32.6% in MENA. High annual case volume (> 200 cases/year) (OR = 3.4, p 

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications